Figure 7.
Endogenous TCR tracking as a broadly applicable method for CAR T cells. Schematic overview of the experimental approach and analytic pipeline for (i) identifying signatures associated with precursors of potent cytotoxic effectors in CAR GMP products, (ii) evaluating effector potential of CAR GMP products, and (iii) enriching CAR GMP products to maximize therapeutic potential.